# What Kidney and Muscle Injury Reports Can Establish

- Article ID: research-409
- Product: Melanotan II (melanotan-ii-444)
- Canonical page: https://heritagebiolabs.com/research-library/articles/409-what-kidney-and-muscle-injury-reports-can-establish
- Product collection: https://heritagebiolabs.com/research-library/products/melanotan-ii
- Product page: https://heritagebiolabs.com/product/melanotan-ii-444
- Reading focus: Study findings (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2012, 2026

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides are short chains of amino acids joined by peptide bonds. Melanotan II is a synthetic peptide that activates melanocortin receptors, some of which are found outside the skin. An October 2026 kidney conference abstract and an emergency medicine case report illustrate why clinicians check laboratory markers and other possible exposures when someone falls ill after reported melanotan use. [1, 2]

The kidney abstract reported a patient whose blood creatinine rose from a prior value of 1.00 to 2.32 milligrams per deciliter after reported Melanotan II exposure. Creatinine is a substance normally cleared by the kidneys; an acute increase can indicate a fall in kidney function. Creatine kinase, a separate marker that can rise when muscle is damaged, peaked at 1,301 units per liter. Imaging showed no kidney infarction or obstruction. The authors proposed reduced kidney blood flow as one explanation, but the abstract did not establish that mechanism. [1]

An older peer-reviewed report documented a different pattern. The authors verified Melanotan II in the material the patient reported using by comparing it with a standard in a laboratory. The patient had kidney dysfunction and a much higher peak creatine kinase, consistent with rhabdomyolysis, or severe muscle breakdown. The older case is useful because it provides both an analytically confirmed product identity and a documented example of substantial muscle injury. [3]

The 2026 emergency medicine report shows why product and exposure verification matter. The patient reported melanotan use, but testing detected a synthetic cannabinoid. The authors considered that confirmed exposure the more likely main cause of the fast heart rate and muscle breakdown and could not confirm the reported melanotan exposure. This case cannot be counted as confirmed injury from Melanotan II. [2]

Each source documents a single patient. Together they show how a rise in creatinine, a rise in a muscle marker and laboratory confirmation of a substance answer different questions. These reports can help identify concerns for follow-up. They cannot tell readers how frequently the events occur or establish a single mechanism that explains them all. [1, 2, 3]

## Sources

1. Faradji D et al. AKI After Recreational Melanotan II Use. American Society of Nephrology Kidney Week (conference abstract, presented 2026-10-24). <https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4557700>
2. Mullins ME, Pentecost G, Li JL. Tachycardia and rhabdomyolysis after use of melanotan and an uncommon synthetic cannabinoid receptor agonist. American Journal of Emergency Medicine (online 2026-10-25). <https://doi.org/10.1016/j.ajem.2026.10.034>
3. Nelson ME, Bryant SM, Aks SE. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clinical Toxicology (online 2012-11-05). <https://pubmed.ncbi.nlm.nih.gov/23121206/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 082 - Melanotan II.docx; article 409; content SHA-256 f3aefaf43ef5efbebfb243f0771d83c632f15538bfb903f1b2fd672206766fcf.
